OraSure Technologies, Inc. (OSUR)

NASDAQ: OSUR · IEX Real-Time Price · USD
2.69
-0.02 (-0.92%)
Jul 1, 2022 1:25 PM EDT - Market open

Company Description

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally.

It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.

saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND genomics laboratory services.

In addition, the company provides ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; offers Colli-Pee collection device for the volumetric collection of first void urine; and manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the academic research and commercial applications, including ancestry, disease risk management, lifestyle, and animal testing.

Further, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities.

OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.

OraSure Technologies, Inc.
OraSure Technologies Logo
Country United States
Founded 2000
IPO Date Nov 12, 1986
Industry Health Care Equipment & Supplies
Sector Health Care
Employees 785
CEO Stephen Tang

Contact Details

Address:
150 Webster St
Bethlehem, Pennsylvania 18015-1338
United States
Phone 610 882 1820
Website orasure.com

Stock Details

Ticker Symbol OSUR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency US Dollars
CIK Code 0001116463
CUSIP Number 68554V108
ISIN Number US68554V1089
Employer ID 36-4370966
SIC Code 3841

Key Executives

Name Position
Scott Gleason Senior Vice President of Investor Relations and Corporate Communications and Interim Chief Financial Officer
Agnieszka M. Gallagher J.D. Executive Vice President, General Counsel, Chief Compliance Officer and Secretary
Kathleen Gallagher Weber President of Molecular Solutions
Carrie Eglinton Manner President, Chief Executive Officer and Director
Michele Marie Miller Senior Vice President, Chief Accounting Officer, Controller and Assistant Secretary
David A. Rappaport C.F.A., CFA Senior Vice President Corporate Development, Strategy and Integration
Amy Steigerwalt Vice President of Human Resources
Lisa Nibauer President of Diagnostics

Latest SEC Filings

Date Type Title
Jun 28, 2022 4 Statement of changes in beneficial ownership of securities
Jun 17, 2022 4 Statement of changes in beneficial ownership of securities
Jun 9, 2022 8-K Current report
Jun 6, 2022 4 Statement of changes in beneficial ownership of securities
Jun 6, 2022 4 Statement of changes in beneficial ownership of securities
Jun 6, 2022 3 Initial statement of beneficial ownership of securities
Jun 2, 2022 4 Statement of changes in beneficial ownership of securities
May 26, 2022 8-K Current report
May 24, 2022 4 Statement of changes in beneficial ownership of securities
May 23, 2022 EFFECT Notice of Effectiveness